Rhodojaponin VI ameliorates podocyte injury related with MDM2/Notch1 pathway in rat experimental membranous nephropathy.
Anni SongRuiwei YanYue QiuXingjie YinJing XiongGuangmin YaoChun ZhangPublished in: Nephrology (Carlton, Vic.) (2024)
Thus, R-VI ameliorates podocyte injury in rats with PHN, which was probably related with MDM2/Notch1 signalling pathway.